DNA synthesis and mitotic machinery

DNA synthesis and mitotic machinery is a broad functional category encompassing the enzymes and structural proteins required for a cell to replicate its genome and divide into two daughter cells. Key components include DNA polymerases, which synthesize new DNA strands; topoisomerases, which manage DNA supercoiling; and microtubules, which form the mitotic spindle necessary for chromosome segregation [StatPearls: Cancer Chemotherapy, Wikipedia: DNA replication]. In clinical practice, this machinery is the primary target of traditional cytotoxic chemotherapy used to treat various forms of cancer [National Cancer Institute: Chemotherapy]. Drugs such as antimetabolites (e.g., methotrexate) inhibit DNA synthesis, while spindle poisons (e.g., taxanes and vinca alkaloids) disrupt mitosis [Nature Reviews Cancer: Targeting the mitotic machinery in cancer]. Because these processes are fundamental to all proliferating cells, drugs targeting this machinery often exhibit a narrow therapeutic index, leading to significant side effects in healthy tissues with high turnover rates, such as the bone marrow and intestinal epithelium [National Cancer Institute: Chemotherapy]. Consequently, while highly effective at inducing tumor regression, these treatments require careful management of systemic toxicities [StatPearls: Cancer Chemotherapy].

Other names

Cell cycle machineryDNA replication and cell division apparatusCytotoxic chemotherapy targets

Inhibition of DNA replication through antimetabolite action or DNA intercalation, and disruption of chromosomal segregation via microtubule stabilization or destabilization [StatPearls: Cancer Chemotherapy, Nature Reviews Cancer: Targeting the mitotic machinery in cancer].